Investor Insights from CEOs & CFOs | Financial Results & Presentations | seat11a
Investor Insights from CEOs & CFOs | seat11a features CEO interviews, CFO interviews, investor presentations, financial results, earnings presentations, elevator pitches, deep dives and strategy updates from publicly listed companies. Discover clear equity stories, business models, growth strategies, ESG updates, capital markets insights and stock market perspectives for private investors, portfolio managers, analysts and anyone following European stocks, global equities and listed company performance.
Mutares SE Financial Results 9M 2026 | Portfolio at Scale, Harvest Under Way
Mutares SE & Co. KGaA Financial Results 9M 2026 | CIO Johannes Laumann – €5.4bn Revenue, Adjusted EBITDA Recovery, Portfolio Exits, Bond Refinancing and FY 2026 Outlook
In this seat11a Financial Results presentation, Johannes Laumann, Chief Investment Officer of Mutares, presents the company's nine-month 2026 financial performance and its strategy under the theme "Portfolio at Scale, Harvest Under Way."
Mutares is a listed private equity investment company specialising in corporate carve-outs, operational restructuring, portfolio transformation and strategic exits.
Mutares 9M 2026 Financial Highlights
• Group revenue: €5.4 billion, compared with €4.7 billion.
• Reported Group EBITDA: €2,052 million, compared with €720 million.
• Adjus...
Hypoport SE Financial Results 9M 2026 | EBIT +27% & Outlook
In this seat11a Financial Results presentation, Ronald Slabke, CEO of Hypoport SE, presents the company’s third-quarter and nine-month 2026 financial performance, including Group revenue, gross profit, operating earnings, mortgage finance volumes, digital platform developments and the company’s full-year outlook.
Hypoport SE, a German technology company specialising in digital platforms for mortgage finance, real estate, housing-sector financing and insurance, continued to achieve profitable growth despite subdued market conditions during the first nine months of 2026. The company’s platform-based business model and market-share gains supported revenue development and operating profitability across its three business segmen...
ZEAL Network SE Financial Results 9M 2026 | Revenue Up 22% & Outlook
In this seat11a Financial Results presentation, the CFO of ZEAL Network SE reviews the first nine months of 2026, including lottery and games performance, SevenCanyon’s contribution and the updated full-year outlook.
Group revenue increased 22.2% to €198.8 million. Reported EBITDA rose 8.6% to €58.7 million, while net profit declined 4.9% to €32.2 million. The prior-year period included a €4.1 million positive one-off deferred tax effect.
• Lottery revenue rose 15.7% to €170.8 million, with €915.1 million in billings and an 18.3% gross margin.
• ZEAL registered 1.007 million new lottery customers, up 15%.
• Games revenue increased 17.7% to €12.1 million as monthly active users increased 27%.
• SevenCanyon contributed €10.5 million in revenue and €1.4 million in EBITDA ...
Amadeus Fire AG Financial Results 9M 2026 | Training Turnaround & Outlook
In this seat11a Financial Results presentation, Jörg Peters, Head of Investor Relations at Amadeus Fire Group, presents the company's Q3 and 9M 2026 results, including revenue development, operating profitability, segment performance and the updated FY 2026 outlook.
• 9M 2026 Group revenue declined 5.7% to €261.5 million, while operating EBITA rose 20.0% to €11.7 million (margin 4.5%).
• Q3 2026 revenue reached €89.8 million (-0.9%); operating EBITA increased about 148% to €8.2 million, a 9.1% margin. EPS returned to €0.43.
• Personnel Services revenue fell 15.6% to €135.8 million in 9M amid a weak German recruitment market.
• The Training segment grew revenue 8.1% to €125.9 million and returned to profitability with €7.5 million operating EBITA.
• FY 2026 guidance confirmed and narrowed: rev...
PALFINGER AG Financial Results 9M 2026 Revenue, Restructuring & Outlook
In this seat11a Financial Results presentation, Felix Strohbichler, CFO of PALFINGER AG, presents the company’s results for the first nine months of 2026. The presentation covers revenue growth, operating profitability, portfolio changes, Russia-related accounting effects, cash flow and the full-year outlook.PALFINGER Q1-Q3 2026 Results: Revenue and Operating EarningsPALFINGER reported revenue of €1,616.7 million, an increase of 3.9% compared with €1,556.3 million in the adjusted prior-year period. EBITDA declined 1.9% to €190.4 million, while EBIT decreased 5.8% to €120.7 million. The EBIT margin reached 7.5%, compared with 8.2% a year earlier.Revenue, EBITDA and EBIT exclude CIS and Tail Lifts. Prior-year comparatives are adjusted in accordance with IFRS 5. Th...
Wacker Chemie AG Financial Results 9M 2026 Earnings Recovery & Outlook
Wacker Chemie AG Financial Results 9M 2026 Earnings Recovery & Outlook
Wacker Chemie AG 9M 2026: Key Takeaways
In this seat11a Financial Results presentation, Joerg Hoffmann, CFA, Head of Investor Relations, presents Wacker Chemie AG’s Q3 2026 results, covering revenue growth, earnings, cash flow, segment performance and the updated full-year outlook. The quarter saw higher sales and profitability, supported by pricing, volume and mix improvements, and the PACE cost and efficiency program.
WACKER Q3 2026 Results: Sales and Earnings Growth
WACKER generated sales of €1.466 billion in the third quar...
Valbiotis Deep Dive 2026 | CEO Sébastien Peltier on Clinical Validation & Commercial Growth
Valbiotis Deep Dive: Key TakeawaysIn this seat11a Deep Dive, Sébastien Peltier, Co-Founder and Chairman of the Management Board of Valbiotis, presents the French listed life sciences company’s transformation from clinical research and biotechnology licensing to commercial growth in natural health products for cardiometabolic health.The presentation covers Valbiotis’ business model, TOTUM-63 clinical validation, REVERSE-IT study results, Nature Communications publication, H1 2026 sales performance, French pharmacy distribution, Valbiotis PRO® product portfolio, China joint venture, Middle East partnerships and international expansion strategy.Valbiotis Scientific Research and TOTUM-63In July 2026, the results of Valbiotis’ REVERSE-IT clinical study involving TOTUM•63 were published...
Valbiotis Elevator Pitch | Clinical Research, Products & Global Growth
Valbiotis Elevator Pitch: Key Takeaways
In this seat11a Elevator Pitch, Sébastien Peltier, Co-Founder and Chairman of the Management Board of Valbiotis, introduces the company’s business model, clinically tested natural health products, commercial growth strategy and international expansion plans.
Valbiotis Business Model and Commercialisation Strategy
Founded in 2014, Valbiotis is a French life sciences company focused on natural solutions for cardiometabolic health. After more than a decade of scientific research and over €60 million invested in research and development, the company has transitioned into commercialisation. Its activities combi...
Wacker Chemie AG Elevator Pitch | A Leader in Specialty Chemicals and Sustainability
WACKER Chemie AG 2026 Capital Markets Day Deep Dive
In this seat11a Deep Dive, Joerg Hoffmann, CFA, Senior Vice President Investor Relations at WACKER Chemie AG, presents a concise recap of the company’s 2026 Capital Markets Day and explains how its new REFOCUS strategy is intended to strengthen profitability, cash generation and returns.
WACKER’s Four Business Segments
WACKER operates through four segments: Silicones, Polymers, Biosolutions and Polysilicon. Each combines differentiated technology with leading or highly specialised market positions. In 2025, the group generated sales of approximately €5.5 billion, serving markets ranging from constru...
Solutiance AG Elevator Pitch | Smartsourcing, AI & Digital Facility Management
Solutiance AG Elevator Pitch Presentation
In this Elevator Pitch on seat11a, Jonas Enderlein, CEO of Solutiance AG, explains how the company combines technology and physical services to digitalise facility management for owners and operators of real estate portfolios.
Digitalising Traditional Facility Management
Solutiance addresses a structural weakness in traditional facility management: services and software are typically separated. Conventional service providers perform the required work on site, but analogue processes can result in inefficient workflows, inconsistent service quality and insufficient data. Standalone software can provide a better technological foundation, but requires implementation, training and upfront investment while still...
BRAIN Biotech AG Financial Results 9M 2025 / 26 | Enzymes, BioIncubator & Outlook
BRAIN Biotech AG 9M 2025/26: Key Takeaways
In this Financial Results presentation on seat11a, Michael Schneiders, CFO of BRAIN Biotech AG, presents the company’s 9M FY 2025/26 Financial Results and discusses the performance of BRAINBiocatalysts and BRAINBioIncubator, profitability, cash flow, financing, the upcoming CEO transition and the updated full-year outlook.
9M FY 2025/26 Revenue and Segment Performance
BRAIN Biotech generated revenue of €34.6 million during the first nine months of FY 2025/26, representing a decline of 10.5% year-on-year. The development primarily reflects weaker performance in BRAINBiocatalysts, where revenue declined 13.3% to €30.8 million. BRAINBioIncubator developed in the opposite direction, increasing revenue 21% to €3.9 million as the company contin...
eDreams ODIGEO Financial Results Q1 2027 | Prime Growth & Global Expansion
eDreams ODIGEO Q1 FY2027 Financial Results Presentation
In this Financial Results presentation on seat11a, Christoph Dieterle, CFO of eDreams ODIGEO, presents the company’s Q1 FY2027 Financial Results and discusses Prime subscriber growth, international and product expansion, profitability, cash generation and the company’s long-term growth strategy.
Prime Subscriber Growth and Q1 FY2027 Performance
eDreams ODIGEO started FY2027 with performance ahead of market estimates, while simultaneously entering the peak investment year of its multi-year strategic roadmap. Prime added 173,000 net subscribers during the quarter, taki...
Kontron AG Financial Results H1 2026 | Defense Growth, Record Backlog & Outlook
Kontron AG First Half 2026 Financial Results Presentation
In this Financial Results presentation on seat11a, Clemens Billek, CFO of Kontron AG, presents the company’s First Half 2026 Financial Results, covering profitability, growth across strategic markets, order momentum, restructuring initiatives and recent commercial developments.
Q2 2026 Profitability and Strategic Market Growth
Kontron delivered further earnings improvement in Q2 2026, with adjusted EBITDA increasing to €55 million, around 20% above both Q1 2026 and the prior-year quarter. The performance was supported by continued growth across several of the Group’s strategic markets, including Defense with 3...
BRAIN Biotech AG Company Presentation | Specialty Enzymes, BioIncubator & Growth Strategy
BRAIN Biotech AG Company Presentation: Key Takeaways
BRAIN Biotech AG Company Presentation
In this Company Presentation on seat11a, Michael Schneiders, CFO of BRAIN Biotech AG, presents the company’s business model, biotechnology platform, growth opportunities and long-term strategy to become one of the world’s leading specialty enzyme companies.
Industrial Biotechnology and Specialty Enzyme Solutions
BRAIN Biotech is an industrial biotechnology company developing specialty enzymes, microorganisms and biological solutions for applications across food, life sciences and industrial markets. The company uses cells, microorganisms and biomolecule...
JOST Werke SE Elevator Pitch | Global leader for mission-critical system for commercial vehicles
JOST Werke SE Elevator Pitch Presentation
In this Elevator Pitch on seat11a, Romy Acosta, Head of Investor Relations at JOST Werke SE, presents the company’s business model, competitive positioning, global footprint and long-term growth ambitions.
Mission-Critical Systems for the Commercial Vehicle Industry
JOST is a global supplier of mission-critical systems for the commercial vehicle industry, serving on-highway transportation as well as off-highway applications across agriculture, construction and mining. Its portfolio includes fifth wheels, landing gears, front loaders, hydraulic cylinders and tipping systems—products that directly influence how commercial vehi...
JOST Werke SE Financial Results H1 2026 | Hyva Integration & Outlook
Presented by Romy Acosta, Head of Investor Relations
In this latest financial results presentation on seat11a, Romy Acosta of JOST Werke SE presents the company’s Q1 2026 financial results and provides an update on current developments across the global commercial vehicle market.
Mixed Market Conditions Across Global Transport Markets
JOST operates as a leading supplier of safety-critical systems for trucks, trailers, agricultural machinery, and off-highway applications. As a globally diversified supplier to transport and logistics markets, the company remains exposed to broader developments in industrial production, freight demand, and co...
Hypoport SE Financial Results H1 2026 Growth Recovery, Platform Momentum & Outlook
Hypoport SE First Half 2026 Financial Results Presentation
In this financial results presentation on seat11a, Ronald Slabke, CEO of Hypoport SE, presents the company's First Half 2026 Financial Results and discusses profitable growth across the Group's Real Estate & Mortgage, Financing and Insurance platforms, continued market share gains, the development of Europace and WOWIPORT, artificial intelligence and the outlook for 2026.
First Half 2026 Financial Performance and Profitable Growth
Hypoport delivered a solid first half despite subdued economic conditions and geopolitical volatility. Revenue increased 5% to €319 million, while gross pr...
ZEAL Network SE Financial Results H1 2026 | Results & Outlook
ZEAL Network SE H1 2026: Key Takeaways
ZEAL Network SE First Half 2026 Financial Results Presentation
In this financial results presentation on seat11a, Andrea Behrendt, CFO of ZEAL Network SE, presents the company’s First Half 2026 Financial Results and discusses record financial performance, operational developments, customer acquisition, product diversification, and strategic expansion into the United Kingdom.
Record First Half 2026 Financial Performance
ZEAL delivered the strongest first half in its corporate history, generating record revenue of €121.8 million, representing year-on-year growth of 20%. EBITDA increased 10% to €38.9 million, corresponding to a margin ...
Amadeus Fire AG Financial Results H1 2026 | Staffing, Training & Outlook
Amadeus Fire AG H1 2026: Key Takeaways
In this financial results presentation on seat11a, Jörg Peters, Head of Investor Relations at Amadeus Fire AG, presents the company’s Q2 and First Half 2026 Financial Results and discusses developments across its Personnel Services and Training segments.
Q2 and First Half 2026 Financial Performance
The first half of 2026 remained challenging for Amadeus Fire as Germany’s weak economic environment continued to impact recruitment activity and corporate hiring decisions. Group revenue declined by 8.0% to €171.7 million, while operating EBITA decreased to €3.5 million and net income amounted to €-3.6 million. Personnel Services continued to f...
Wacker Chemie AG Financial Results H1 2026 | Results & Outlook
Wacker Chemie AG Q1 2026: Key Takeaways
WACKER Chemie AG First Half 2026 Financial Results Presentation
In this financial results presentation on seat11a, Jörg Hoffmann, Head of Investor Relations at WACKER Chemie AG, presents the company’s First Half 2026 Financial Results and discusses financial performance, business segment developments, operational improvements, and the updated outlook for the year.
First Half 2026 Financial Performance
During the second quarter of 2026, WACKER increased sales by 7% year-on-year to €1.52 billion. Reported EBITDA rose to €211 million, while EBITDA before special effects reached €175 million, supported...
Palfinger AG Elevator Pitch | Technology Leadership & Growth Strategy
Palfinger AG Elevator Pitch: Key Takeaways
PALFINGER AG Elevator Pitch Presentation
In this Elevator Pitch on seat11a, Felix Strohbichler, CFO of PALFINGER AG, presents the company’s business model, competitive strengths, strategic priorities, and long-term growth ambitions.
Global Technology Leader in Crane and Lifting Solutions
PALFINGER is a global technology leader in crane and lifting solutions, serving customers across a wide range of industries through an extensive product portfolio, a global service network, and strong local market positions. The company’s strategy is built around technology leadership, operational r...
PALFINGER AG Financial Results H1 2026 Revenue Growth Despite Headwinds
PALFINGER AG First Half 2026 Financial Results Presentation
In this financial results presentation on seat11a, Felix Strohbichler, CFO of PALFINGER AG, presents the company's First Half 2026 Financial Results and discusses financial performance, regional business developments, cash generation, balance sheet improvements, and the outlook for the remainder of the year.
First Half 2026 Financial Performance
PALFINGER generated revenue of €1.17 billion during the first half of 2026, representing year-on-year growth despite a mixed market environment. EBITDA reached €133.3 million, while EBIT amounted to €84.1 million and net profit totaled €48.0 million. Management explained that earnings were affected by weaker demand in North America, the Middle E...
BRAIN Biotech Elevator Pitch | Enzyme, Biotechnologie und Wachstumsstrategie
In diesem seat11a Elevator Pitch stellt Michael Schneiders, CFO der BRAIN Biotech AG, das Geschäftsmodell, die Technologieplattform und die langfristige Wachstumsstrategie des Unternehmens vor.BRAIN Biotech ist ein Unternehmen der industriellen Biotechnologie und entwickelt Enzyme, Mikroorganismen sowie biologische Lösungen für Kunden aus den Bereichen Lebensmittel, Getränke, Life Sciences sowie weiteren Spezialmärkten. Mit seinen Produkten unterstützt das Unternehmen die Biologisierung industrieller Prozesse und den Übergang zu nachhaltigeren Produktionsverfahren.Das Geschäftsmodell basiert auf zwei komplementären Säulen. BRAINBiocatalysts bündelt das operative Geschäft mit Spezialenzymen, Mikroorganismen sowie Forschungs-, Entwicklungs- und Produktionsdienstleistungen. BRAINBioIncu...
BRAIN Biotech AG Elevator Pitch | Enzymes, Bioeconomy & Innovation
Key Takeaways
BRAIN Biotech AG Elevator Pitch Presentation
In this seat11a Elevator Pitch, Michael Schneiders, CFO of BRAIN Biotech AG, presents the company’s business model, biotechnology platform, and long-term growth strategy.
Biotechnology Platform for Sustainable Industrial Solutions
BRAIN Biotech develops enzyme products, microorganisms, and biological solutions that help customers replace conventional industrial processes with more sustainable biotechnology-based alternatives. The company serves customers across food, beverage, life sciences, proteins, dairy, and other specialty industrial markets through its integrated biotechnology platform.
...
eDreams ODIGEO Deep Dive | How eDreams Uses AI
eDreams ODIGEO's Deep Dive: Key Takeaways
eDreams ODIGEO Artificial Intelligence Deep Dive
In this deep dive presentation on seat11a, David Elizaga explains how Artificial Intelligence has become a core component of eDreams ODIGEO’s business model and long-term growth strategy.
Artificial Intelligence as a Core Business Component
Management describes eDreams as an AI-first company for more than a decade, emphasizing that AI has been integrated into the business long before the recent surge of interest in generative AI technologies. Today, AI supports multiple areas of the company, in...
Matador AG Deep Dive | SpaceX, Private Equity & Portfolio Strategy
Matador AG Deep Dive: Key Takeaways
Matador Secondary Private Equity AG Deep Dive Presentation
In this deep dive presentation on seat11a, Alexander Lachmann, CFO of Matador Secondary Private Equity AG, explains how the company provides investors with access to a diversified private equity portfolio and a broad range of innovative private companies.
Diversified Private Equity Portfolio Built Over Two Decades
Over the past two decades, Matador has built a portfolio through investments with leading international private equity managers. The company focuses primarily on small...
Amoeba SA Elevator Pitch | Biocontrol, Cosmetics & Commercial Growth
Amoeba SA Elevator Pitch: Key Takeaways
Amoéba SA Elevator Pitch Presentation
In this Elevator Pitch on seat11a, Jean-François Doucet, CEO of Amoéba SA, presents the company’s strategy, technology platform and commercial development plans across agriculture and cosmetics.
A Green Technology Company Built on Proprietary Amoeba Cultivation
Amoéba is a French green technology company specializing in natural bio-solutions derived from proprietary amoeba cultivation technology. The company has spent more than a decade developing a unique industrial platform and has built a port...
eDreams ODIGEO Financial Results FY 2026 | Results & Strategic Roadmap
eDreams ODIGEO's FY 2026 Key Takeaways
Presented by David Elizaga, CFO
In this latest financial results presentation on seat11a, David Elizaga presents the company’s FY 2026 financial results and provides an update on Prime subscriber growth, profitability development, artificial intelligence initiatives, and the company’s long-term strategic roadmap.
Record Profitability and Continued Prime Growth
eDreams ODIGEO delivered results ahead of expectations during FY26, supported by continued growth of its Prime subscription platform. Prime membership increased by 9% to 7.9 million subscribers, while Adjusted EBITDA rose...
BRAIN Biotech AG Financial Results H1 2025 / 26 | Enzymes, CRISPR, BioIncubator projects, and bioeconomy innovation.
BRAIN Biotech AG 6M FY 2025/26: Key Takeaways
Presented by Michael Schneiders, CFO
In this latest financial results presentation on seat11a, Michael Schneiders of BRAIN Biotech AG presents the company’s 6M FY 2025/26 financial results and provides an update on operational developments across its enzyme business and BioIncubator activities.
Industrial Biotechnology Platform with Two-Pillar Structure
BRAIN Biotech continues to position itself as a provider of industrial biotechnology solutions, combining enzyme technologies, microbial systems, and biotechnology-driven industrial applications across food, life sciences, chemicals, health, and sustainability-related ma...
Kontron AG Financial Results Q1 2026 | Software Infrastructure Technology Developments
Kontron AG Q1 2026: Key Takeaways
Presented by Clemens Billek, CFO
In this latest financial results presentation on seat11a, Clemens Billek of Kontron AG presents the company’s Q1 2026 financial results and provides an update on operational developments across its IoT, software, and digital infrastructure businesses.
Positioned Across Key Digitalisation Trends
Kontron continues to position itself as a leading European provider of IoT technologies, embedded computing systems, and smart infrastructure solutions, serving customers across industrial automation, transportation, telecommunications, energy, aerospace, defense, and public sector markets.
Kontron AG Financial Results FY 2025 | IoT, Software & Digital Infrastructure
Kontron AG FY 2025: Key Takeaways
Presented by Clemens Billek, CFO
In this latest financial results presentation on seat11a, Clemens Billek of Kontron AG presents the company’s full year 2025 financial results and provides an update on operational developments across its IoT, software, and digital infrastructure businesses.
Positioning Around Long-Term Digitalisation Trends
Kontron continues to position itself as a leading European provider of IoT technologies, embedded computing systems, and smart infrastructure solutions, serving customers across industrial automation, transportation, telecommunications, energy, aerospace, and public sector applications.
...JOST Werke SE Financial Results Q1 2026 | Truck market, CV demand, margins, and operations insights.
JOST Werke SE Q1 2026: Key Takeaways
Presented by Romy Acosta, Head of Investor Relations
In this latest financial results presentation on seat11a, Romy Acosta of JOST Werke SE presents the company’s Q1 2026 financial results and provides an update on current developments across the global commercial vehicle market.
Mixed Market Conditions Across Global Transport Markets
JOST operates as a leading supplier of safety-critical systems for trucks, trailers, agricultural machinery, and off-highway applications. As a globally diversified supplier to transport and logistics markets, the company re...
Palfinger AG Elevator Pitch | Overview of business model global and growth strategy
Palfinger AG Elevator Pitch: Key Takeaways
PALFINGER AG Elevator Pitch: Business Model, Strategy and Growth Drivers
Presented by Felix Strohbichler
In this elevator pitch on seat11a, Felix Strohbichler of Palfinger AG provides a concise overview of the company’s business model, strategic positioning, and key growth drivers.
Global Leader in Lifting and Crane Solutions
PALFINGER is a global leader in lifting and crane solutions, with a broad portfolio spanning loader cranes, marine equipment, and specialized lifting systems. The company operates in a wi...
Hypoport SE Financial Results Q1 2026 | Growth Recovery, Platform Momentum & Outlook Germany
Hypoport SE Q1 2026: Key Takeaways
Hypoport SE Q1 2026 Financial Results
Presented by Ronald Slabke, CEO
In this latest financial results presentation on seat11a, Ronald Slabke of Hypoport SE presents the company’s Q1 2026 financial results and provides an update on current developments across its digital finance and real estate platform ecosystem.
Gradual Stabilisation in the German Mortgage Market
Hypoport remains one of the key listed technology-driven infrastructure providers for the German mortgage and financial services market. Through platforms such as Europace, the co...
Amadeus Fire AG Financial Results Q1 2026 | Stabilisation, Training & Outlook
Amadeus Fire AG Q1 2026: Key Takeaways
Presented by Jörg Peters, Head of Investor Relations
In this latest financial results presentation on seat11a, Jörg Peters, Head of Investor Relations of Amadeus Fire Group, presents the company’s Q1 2026 financial results and provides an update on current business trends across the Personnel Services and Training segments.
Challenging Macro Environment Continues to Impact Personnel Services
Amadeus Fire started the year in a still difficult macroeconomic environment in Germany, with weak economic growth, high...
ZEAL Network SE Financial Results Q1 2026 | Growth, Games & Lottery Expansion
ZEAL Network SE Q1 2026: Key Takeaways
Presented by Andrea Behrendt, CFO
In this latest financial results presentation on seat11a, Andrea Behrendt of ZEAL Network SE presents the company’s Q1 2026 financial results and provides an update on customer growth, lottery billings, games performance, and ZEAL’s strategic expansion initiatives.
Continued Growth Despite Weak Jackpot Environment
ZEAL delivered continued growth in the first quarter despite what management described as a particularly weak jackpot environment. Neither Lotto 6aus49 nor Eurojackpot reached peak jackpot levels during Q1 2026, creating difficult conditions for...
Wacker Chemie AG Financial Results Q1 2026 | Demand Trends, Pricing & Outlook
Wacker Chemie AG Q1 2026: Key Takeaways
WACKER Chemie AG Q1 Financial Results: Joerg Hoffmann on Performance, Market Trends and Segment Developments
Presented by Joerg Hoffmann, Head of Investor Relations
In this latest financial results presentation on seat11a, Joerg Hoffmann of Wacker Chemie AG provides an update on the company’s Q1 financial performance, recent business developments, and the current trading environment across its key segments.
Q1 Performance in a Mixed Market Environment
WACKER Chemie started the year in a still mixed market environment, with demand tr...
PALFINGER AG Financial Results Q1 2026 | Revenue, Profitability and the 2026 Outlook
PALFINGER AG Q1 2026: Key Takeaways
Presented by Felix Strohbichler, CFO
In this seat11a presentation, PALFINGER CFO Felix Strohbichler provides a detailed overview of the company’s Q1 2026 financial results and discusses the key developments that shaped the start to the year. The presentation covers PALFINGER’s first quarter performance, operational progress, current market dynamics and management’s priorities for the quarters ahead.
Overview of PALFINGER’s Q1 2026 Financial Results
Felix Strohbichler outlines how PALFINGER performed in the opening months of 2026 and explains the main factors that influenced the quar...
Mutares SE Financial Results FY 2025 | Results & Portfolio Update
Mutares SE FY 2025: Key Takeaways
Mutares FY 2025 Financial Results: Johannes Laumann Explains Strong Earnings, Exit Momentum and the Next Phase of Growth
Presented by Johannes Laumann, CIO
Mutares SE & Co. KGaA has built one of the most distinctive listed investment models in the European market. Rather than operating as a traditional industrial company, Mutares is a special situations private equity platform focused on acquiring businesses in transition, executing deep operational improvements, and ultimately monetising those investments through strategic exits. In this seat11a presentation, Johannes Laumann, CIO...
Amadeus Fire AG Deep Dive | Guidance, Recovery & AI Strategy
In this seat11a deep dive presentation, Robert von Wülfing, CEO of Amadeus Fire Group, takes investors through the company’s 2026 outlook and explains where management sees the most important drivers of revenue recovery, margin improvement, and earnings growth after a difficult FY 2025.
Why the FY 2026 Outlook Matters for Investors
Following a challenging 2025 marked by weak demand, lower hiring activity, delayed corporate decisions, and pressure across both the Personnel Services and Training segments, Amadeus Fire is now guiding for a visible recovery in FY 2026. Management’s outlook includes group revenue of aroun...